The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care

The High Cost of Insulin: Bridging Gaps on Path to Affordable Care

Why are insulin prices so high? Short history from development to today’s price hikes Doctors Frederick Banting and Charles Best successfully isolated the hormone insulin just over 100 years ago, dramatically changing the lives of those with diabetes. When Nobel Prize Winner Banting discovered insulin, out of ethical consideration, he refused to put his name […]

The Price of Insulin: The Real Cost of Diabetes

“Insulin is a remedy primarily for the wise and not for the foolish, be they patients or doctors. Everyone knows it requires brains to live long with diabetes, but to use insulin successfully requires more brains.” – Elliott P. Joslin, 1923 This year, the medical community simultaneously celebrates the 100-year anniversary of the first use […]

Cybersecurity Concerns with Medtronic Insulin Pumps

Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has been used in the treatment of diabetes for decades. Devices have evolved with technological advancements; some insulin pumps now feature Bluetooth connectivity and complementary smartphone applications while the use of AI technology is slowly being integrated. Modern insulin pumps are both more patient and physician-friendly […]

First “Follow-On” Insulin Now Available in the United States

One year after the US FDA granted approval to the first “follow-on” insulin, the long-acting insulin glargine product has been officially launched in the United States. Approved as a follow-on and not a biosimilar, the long-acting insulin glargine has already been made available in Europe, and is available as a 100 Units/mL strength in 3-mL […]

Insulin Degludec/Liraglutide 1 Step Closer to US FDA Approval

An FDA advisory committee has voted unanimously in favor of approval of the combination type 2 diabetes treatment insulin degludec/liraglutide. The panel also agreed that the combination treatment would at least be appropriate for patients who had previously used an insulin analogue or GLP-1 agonist, but no other consensus was reached regarding which patient types […]


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.